Efficacy, Safety, and Acceptability of Ayush BR Leham as an Adjuvant to the Supplementary Nutrition Programme under ICDS in the Management of Moderate Malnutrition among Children aged 3- 5 years from Anganwadi centres - A cluster randomized controlled clinical trial - NI

Central Council for Research in Ayurvedic Sciences, New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•1. Age group between 3-5 years of either sex
•2. Weight-for-Height Z scores =-2 SD and = -3 SD of the median as per WHO Child Growth Standards
•3. Absence of Edema
•4. Studying in Anganwadi Centre run by ICDS
•5. Will not share medication with others
•6. Parents/guardians willing to provide a written informed consent form for the participation of their children.

•1. Presenting with acute infections e.g. Acute respiratory tract infection, diarrhea, etc. (Temporary Exclusion)
•2. Weight for Height Z score less than -3 SD of the median as per WHO Child Growth Standards
•3. Presence of edema
•4. On any medication for the last two months except vitamins and Minerals.
•5. Underlying chronic diseases that may affect growth (cardiac, renal, tuberculosis, liver disease, HIV/AIDS)
•6. Child with neurological and hereditary disease
•7. Child with congenital abnormalities
•8. Any other condition that the Investigator thinks may jeopardize the study.

发起方

Central Council for Research in Ayurvedic Sciences, New Delhi